Skip to content
The Policy VaultThe Policy Vault

XareltoMedical Mutual

Coronary Artery Disease

Initial criteria

  • Patient will be taking concomitant aspirin at least 75 mg daily

Reauthorization criteria

  • Response to therapy is required for continuation unless otherwise noted

Approval duration

2 years